Pulmonale Manifestationen von neuroendokrinen Tumoren

TumorDiagnostik & Therapie 2017; 38(01): 51-55
DOI: 10.1055/s-0042-124566

Thieme Onkologie aktuell

Pulmonary neuroendocrine tumors

Manuel Kolb

¹Diagnostische und Interventionelle Radiologie; Universitätsklinikum Tübingen

,

Hans Bösmüller

²Allgemeine Pathologie und Pathologische Anatomie, Universitätsklinikum Tübingen

,

Marius Horger

¹Diagnostische und Interventionelle Radiologie; Universitätsklinikum Tübingen

Literatur
1 Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med 2010; 134: 1628-1638
2 Capella C. et al. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995; 425: 547-560
3 Travis WD. et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 2015; 10: 1243-1260
4 Chassagnon G. et al. DIPNECH: when to suggest this diagnosis on CT. Clin Radiol 2015; 70: 317-325
5 Nassar AA. et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am J Respir Crit Care Med 2011; 184: 8-16
6 Buchmann I. et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2007; 34: 1617-1626
7 Wolin EM. Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations. Oncologist 2015; 20: 1123-1131
8 Mandegaran R. David S. Screaton N. Cardiothoracic manifestations of neuroendocrine tumours. Br J Radiol 2016; 89: 20150787
9 Naidoo J. et al. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. Clin Lung Cancer 2016; 17: e121-e129
10 van Meerbeeck J. et al. Small-cell lung cancer. Lancet 2011; 378: 1741-1755